Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: tdl4138 who wrote (20239)	3/12/1999 6:08:00 PM
From: Katelew	Respond to of 122087

Boy I hope I didn't dream this....been trying to find what I read since I posted. I came across it on Tues. or Wed. and it wasn't mentioned relative to ENMD. I think it was something I was reading that was coming out of the biotech conference that's going on this week. Anyway, I'm going to keep looking. As far as the news not affecting ENMD.....ther are several co. working on angiostatiin, inc. BMY.

To: tdl4138 who wrote (20239)	3/12/1999 7:04:00 PM
From: Katelew	Respond to of 122087

Dave...I can't find whatever it was that I read. I may have gotten confused over GNE's work with angiogenesis>>trying to stimulate new blood vessel growwth to treat heart disease, but I really don't think so. On the other hand, your're probably right that whatever it was I thought I read should have stimulated the stock more or made headlines or something. If it was important info, it'll surface again.....but if you should track this down, please let me know so I don't think I've lost my mind!!! Sorry, Daisy